Skip to main content

Prevnar 13 News

Pfizer Receives FDA Approval for Prevnar 13 in Adults Age 18 Through 49

July 12, 2016 - Pfizer Inc. (NYSE:PFE) today announced that Prevnar 13 (Pneumococcal 13-valent Conjugate Vaccine [Diphtheria CRM197 Protein]) received U.S. Food and Drug Administration (FDA) approval...

FDA Expands Use of Prevnar 13 Vaccine for People Ages 50 and Older

SILVER SPRING, Md., Dec. 30, 2011 /PRNewswire-USNewswire/ – Prevnar 13, a pneumococcal 13-valent conjugate vaccine, was approved today by the U.S. Food and Drug Administration for people ages 50...

Ask a question

To post your own question to our community, sign in or create an account.

Further information

Prevnar 13 patient information at Drugs.com